Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.


financial news 260x173First Quarter 2020 Financial Results

Genmab reported its First Quarter 2020 financial results and held an investor conference call on May 6. Click here to download the report, here to listen to a replay of the webcast and here to download the conference call slides.  


join our team_260x173Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.    



Investorportal sign on_260x173InvestorPortal

To register your email address for electronic shareholder communications or to update your settings, log on to the InvestorPortal

Latest news

Genmab - Using Science to Turn Insights into Medicine 

  • Watch a short video to learn more about Genmab

Genmab 2020 Corporate Video

Stock Info